Gene · 1364
Papers3,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies. | J Clin Med | 2023 | 37109309 | PubTator, text mining | PubMed |
| Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease. | J Pers Med | 2023 | 37109050 | PubTator, text mining | PubMed |
| Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing. | Int J Mol Sci | 2023 | 37108564 | PubTator, text mining | PubMed |
| The Cytoprotective Effects of Baicalein on H2O2-Induced ROS by Maintaining Mitochondrial Homeostasis and Cellular Tight Junction in HaCaT Keratinocytes. | Antioxidants (Basel) | 2023 | 37107277 | PubTator, text mining | PubMed |
| Cloning a profibrotic stem cell variant in idiopathic pulmonary fibrosis. | Sci Transl Med | 2023 | 37099633 | PubTator, text mining | PubMed |
| TWEAK Signaling-Induced ID1 Expression Drives Malignant Transformation of Hepatic Progenitor Cells During Hepatocarcinogenesis. | Adv Sci (Weinh) | 2023 | 37085918 | PubTator, text mining | PubMed |
| Comprehensive epithelial biomarker analysis of malignant mesothelioma: EpCAM positivity is a potential diagnostic pitfall. | Cancer Cytopathol | 2023 | 37069606 | PubTator, text mining | PubMed |
| Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma. | Virchows Arch | 2023 | 37067588 | PubTator, text mining | PubMed |
| CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer. | Front Immunol | 2023 | 37063862 | PubTator, text mining | PubMed |
| Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor β. | Breast Cancer Res | 2023 | 37059993 | PubTator, text mining | PubMed |
| CLDN4 as a Novel Diagnostic and Prognostic Biomarker and Its Association with Immune Infiltrates in Ovarian Cancer. | Mediators Inflamm | 2023 | 37057131 | PubTator, text mining | PubMed |
| Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management. | Food Sci Nutr | 2023 | 37051344 | PubTator, text mining | PubMed |
| Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab. | Front Immunol | 2023 | 37051241 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma. | Sci Adv | 2023 | 37043580 | PubTator, text mining | PubMed |
| Comprehensive Metabolic Profiling and Genome-wide Analysis Reveal Therapeutic Modalities for Hepatocellular Carcinoma. | Research (Wash D C) | 2023 | 37040510 | PubTator, text mining | PubMed |
| Calcitriol modifies tight junctions, improves barrier function, and reduces TNF-α-induced barrier leak in the human lung-derived epithelial cell culture model, 16HBE 14o. | Physiol Rep | 2023 | 37038908 | PubTator, text mining | PubMed |
| Intraductal oncocytic papillary neoplasm (IOPN): two case reports and review of the literature. | Transl Cancer Res | 2023 | 37033351 | PubTator, text mining | PubMed |
| Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis. | Prog Retin Eye Res | 2023 | 37028118 | PubTator, text mining | PubMed |
| Lipocalin 2 - mutation screen and serum levels in patients with anorexia nervosa or obesity and in lean individuals. | Front Endocrinol (Lausanne) | 2023 | 37025415 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1364/papers?page=26